Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression.

Literature DB >> 19229048

CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression.

Lisa M Rimsza, Wing C Chan, Randy D Gascoyne, Elias Campo, Elaine S Jaffe, Louis M Staudt, Jan Delabie, Andreas Rosenwald, Shawn P Murphy.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2009 PMID： 19229048 PMCID： PMC2663627 DOI： 10.3324/haematol.2008.000752

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

× No keyword cloud information.

9 in total

Review 1. Class II transactivator: mastering the art of major histocompatibility complex expression.

Authors: J A Harton; J P Ting
Journal: Mol Cell Biol Date: 2000-09 Impact factor: 4.272

Review 2. Genetic control of MHC class II expression.

Authors: Jenny Pan-Yun Ting; John Trowsdale
Journal: Cell Date: 2002-04 Impact factor: 41.582

Review 3. When the lymphocyte loses its clothes.

Authors: Nada Nekrep; Joseph D Fontes; Matthias Geyer; B Matija Peterlin
Journal: Immunity Date: 2003-04 Impact factor: 31.745

4. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.

Authors: Alyssa B Long; Angela M Ferguson; Parimal Majumder; Uma M Nagarajan; Jeremy M Boss
Journal: Mol Immunol Date: 2005-04-12 Impact factor: 4.407

5. Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.

Authors: Lisa M Rimsza; Michael L Leblanc; Joseph M Unger; Thomas P Miller; Thomas M Grogan; Daniel O Persky; Ralph R Martel; Constantine M Sabalos; Bruce Seligmann; Rita M Braziel; Elias Campo; Andreas Rosenwald; Joseph M Connors; Laurie H Sehn; Nathalie Johnson; Randy D Gascoyne
Journal: Blood Date: 2008-06-10 Impact factor: 22.113

6. Characterization of the expressed CIITA allele in the class II MHC transcriptional mutant RJ2.2.5.

Authors: J A Brown; X F He; S D Westerheide; J M Boss
Journal: Immunogenetics Date: 1996 Impact factor: 2.846

7. The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.

Authors: J A Brown; E M Rogers; J M Boss
Journal: Nucleic Acids Res Date: 1998-09-15 Impact factor: 16.971

8. Distribution patterns of dendritic cells and T cells in diffuse large B-cell lymphomas correlate with prognoses.

Authors: Kung-Chao Chang; Guan-Cheng Huang; Dan Jones; Ya-Hui Lin
Journal: Clin Cancer Res Date: 2007-11-15 Impact factor: 12.531

9. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Authors: Andreas Rosenwald; George Wright; Wing C Chan; Joseph M Connors; Elias Campo; Richard I Fisher; Randy D Gascoyne; H Konrad Muller-Hermelink; Erlend B Smeland; Jena M Giltnane; Elaine M Hurt; Hong Zhao; Lauren Averett; Liming Yang; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; John Powell; Patricia L Duffey; Dan L Longo; Timothy C Greiner; Dennis D Weisenburger; Warren G Sanger; Bhavana J Dave; James C Lynch; Julie Vose; James O Armitage; Emilio Montserrat; Armando López-Guillermo; Thomas M Grogan; Thomas P Miller; Michel LeBlanc; German Ott; Stein Kvaloy; Jan Delabie; Harald Holte; Peter Krajci; Trond Stokke; Louis M Staudt
Journal: N Engl J Med Date: 2002-06-20 Impact factor: 91.245

9 in total

12 in total

1. Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma.

Authors: Sarah T Wilkinson; Kristie A Vanpatten; Diane R Fernandez; Patrick Brunhoeber; Karl E Garsha; Betty J Glinsmann-Gibson; Thomas M Grogan; Julie Teruya-Feldstein; Lisa M Rimsza
Journal: Blood Date: 2011-12-13 Impact factor: 22.113

2. Coordinate loss of MHC class II expression in the diffuse large B cell lymphoma cell line OCI-Ly2 is due to a novel mutation in RFX-AP.

Authors: Meghan Bushway; Kelly A Cycon; Kathleen Mulvaney; Shawn P Murphy
Journal: Immunogenetics Date: 2009-12-19 Impact factor: 2.846

3. Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma.

Authors: Samantha Kendrick; Lisa M Rimsza; David W Scott; Graham W Slack; Pedro Farinha; King L Tan; Daniel Persky; Soham Puvvada; Joseph M Connors; Laurie Sehn; Randy D Gascoyne; Monika Schmelz
Journal: Virchows Arch Date: 2016-11-25 Impact factor: 4.064

Review 4. Genetic lesions in diffuse large B-cell lymphomas.

Authors: M Testoni; E Zucca; K H Young; F Bertoni
Journal: Ann Oncol Date: 2015-01-20 Impact factor: 32.976

Review 5. Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine.

Authors: Ruifang Sun; L Jeffrey Medeiros; Ken H Young
Journal: Mod Pathol Date: 2016-08-01 Impact factor: 7.842

6. Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV.

Authors: Sarah T Wilkinson; Diane R Fernandez; Shawn P Murphy; Rita M Braziel; Elias Campo; Wing C Chan; Jan Delabie; Randy D Gascoyne; Louis M Staudt; Elaine S Jaffe; Andreas Rosenwald; Lisa M Rimsza
Journal: Leuk Lymphoma Date: 2009-11

10. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.

Authors: P J Brown; K K Wong; S L Felce; L Lyne; H Spearman; E J Soilleux; L M Pedersen; M B Møller; T M Green; D M Gascoyne; A H Banham
Journal: Leukemia Date: 2015-10-26 Impact factor: 11.528